Valuation: Boule Diagnostics AB

Market Cap 40.19M 4.09M 3.66M 3.37M 3.05M 5.71M 388M 5.82M 16.13M 204M 15.35M 15.03M 644M P/E 2026 *
-4.11x
P/E 2027 * 4.68x
Enterprise Value 237M 24.1M 21.58M 19.85M 17.99M 33.62M 2.29B 34.25M 95.03M 1.2B 90.44M 88.51M 3.8B EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.46x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 week-49.51%
Current month-55.39%
1 month-54.41%
3 months-71.57%
6 months-71.33%
Current year-78.92%
1 week 0.94
Extreme 0.944
1.25
1 month 0.94
Extreme 0.944
2.83
Current year 0.94
Extreme 0.944
5.68
1 year 0.94
Extreme 0.944
6.64
3 years 0.94
Extreme 0.944
12.62
5 years 0.94
Extreme 0.944
59.5
10 years 0.94
Extreme 0.944
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/2/23 Buy

Chief Financial Officer

8,000 0.0206%
6/2/23 Buy

Director

7,083 0.0182%
17/2/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-49.51%-83.14%-88.56% 4.08M
-1.72%+3.44%+25.31%+60.56% 262B
-2.00%+0.75%+7.99%+25.46% 167B
-3.73%-4.48%-18.49%+67.13% 156B
-1.66%-8.12%-58.26%-16.12% 61.87B
-2.57%+3.30%+10.22%+47.55% 54.44B
0.00%+2.71%-13.09%-6.48% 53.3B
-3.47%+1.04%+21.98%+72.85% 51.07B
+0.84%-3.12%+9.80%+64.47% 50.25B
-3.61%+1.99%+34.94%+95.49% 47.17B
Average -1.71%-3.44%-6.27%+32.23% 90.26B
Weighted average by Cap. -1.95%+2.44%+5.11%+47.95%

Financials

2026 *2027 *
Net sales 453M 46.12M 41.31M 38M 34.43M 64.36M 4.38B 65.56M 182M 2.3B 173M 169M 7.27B 483M 49.2M 44.06M 40.53M 36.72M 68.65M 4.67B 69.93M 194M 2.46B 185M 181M 7.75B
Net income -9.77M -995K -891K -820K -743K -1.39M -94.46M -1.41M -3.92M -49.69M -3.73M -3.65M -157M 8.6M 875K 784K 721K 653K 1.22M 83.08M 1.24M 3.45M 43.7M 3.28M 3.21M 138M
Net Debt 197M 20.01M 17.92M 16.48M 14.93M 27.91M 1.9B 28.44M 78.9M 999M 75.08M 73.49M 3.15B 185M 18.78M 16.82M 15.47M 14.02M 26.21M 1.78B 26.7M 74.07M 938M 70.49M 68.99M 2.96B
Projected Income Statement - Annual - Boule Diagnostics AB
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
30/10/26 SEK 1.035 0.00% 24,508
29/10/26 SEK 1.035 +0.49% 32,279
28/10/26 SEK 1.030 -6.36% 280,076
27/10/26 SEK 1.100 -1.35% 136,981
26/10/26 SEK 1.115 -8.98% 805,179
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Boule Diagnostics AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.035SEK
Average target price
3.800SEK
Spread / Average Target
+267.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boule Diagnostics AB
  1. Stock Market
  2. Stocks
  3. BOUL Stock